CYNTHIA COENEN: Open Payments
NPI 1467907394 · DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,468 in 77 payments from 16 companies in 2025. Trend: 2023 $1,580 · 2024 $1,433 · 2025 $1,468
Food & beverage: $1,468
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 14 | $264 |
| ABBVIE INC. | 12 | $222 |
| Vanda Pharmaceuticals Inc. | 10 | $170 |
| Teva Pharmaceuticals USA, Inc. | 6 | $140 |
| Lundbeck LLC | 5 | $111 |
| Corium, LLC | 5 | $96 |
| Janssen Pharmaceuticals, Inc | 3 | $58 |
| E.R. Squibb & Sons, L.L.C. | 3 | $55 |
| Alkermes, Inc. | 3 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $52 |
Products named: REXULTI, VRAYLAR, FANAPT, UZEDY, Azstarys, INVEGA SUSTENNA, COBENFY, ABILIFY ASIMTUFII.
Industry payments across IA — which companies pay providers there.
